Meeting Agenda

Agenda

MEETING OBJECTIVE:

 

To examine the perceived value of genetic and genomic technologies, both present and future, in clinical practice

• How do different stakeholders define the value of genetic and genomic technologies?   

• How do stakeholders evaluate the weight of one kind of value in relation to another? 

• How do people assess relative values to make health care decisions?

• How do these types of value relate, or not relate, to the monetary cost of the technologies?

 

8:00 – 8:15 A.M.      PUBLIC WORKSHOP BEGINS — AUDITORIUM

 

8:00 – 8:15 a.m.        Welcome and Introductory Remarks

                                             Wylie Burke, Roundtable Chair and Professor and Chair of the Department of Medical History and Ethics, University of Washington

 

8:15 – 10:15 a.M.    correlation between Lynch Syndrome and Colon Cancer

 

8:15 – 8:30 a.m.        Presentation

                                             Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital

 

8:30 – 9:00 a.m.        Lynch Syndrome Panelists

                                             Andrew Spiegel, CEO, Colon Cancer Alliance

                                             Mark Boguski, Associate Professor, Center for Biomedical Informatics, Harvard Medical School

                                             Roy Gandolfi, Associate Medical Director, SelectHealth

                                             Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT

                                             Don Lyman, Chief, Chronic Disease and Injury Control                                                                           Division, California Department of Public Health           

 

9:00 – 9:45 a.m.        Panel discussion

 

9:45 – 10:15 a.m.      Roundtable discussion

 

10:15 – 10:30 a.m.   Break

 

10:30 – 12:30 p.M.   Pharmacogenomic testing for Warfarin dosing

 

10:30 – 10:45 a.m.    Presentation

                                             David Veenstra, Associate Professor, Pharmaceutical Outcomes Research and Policy Program and Institute for Public Health Genetics, University of Washington

                                   

10:45 – 11:15 a.m.    Warfarin Panelists

                                             Anna Garrett, Manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, NC

                                             Elizabeth Mansfield, Director of the Personalized Medicine Staff, Office of In Vitro Diagnostic Devices, Center for Devices and Radiological Health, FDA and Senior Genomics and Personalized Medicine Advisor, Office of the Chief Scientist, FDA

                                             Arthur Lurvey, Medical Director, Palmetto GBA

                                             Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT                        

 

11:15 – 12:00 p.m.    Panel discussion

 

12:00 – 12:30 p.m.    Roundtable discussion

 

12:30 – 1:30 p.m.     lunch

 

1:30 – 4:00 p.m.      genomic profiling

 

1:30 – 1:45 p.m.        Presentation

                                             Bruce Blumberg, Co-chief of Medical Genetics, Kaiser-Permanente, Oakland and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group

                                   

1:45 – 2:15 P.M.        Genomic Profiling Panelists

                                             Janet Williams, Genetic Counselor, Intermountain Healthcare, Oncology Clinics

                                             David Witt, Genetics Department, Kaiser San Jose Medical Center

                                             Karen Kaplan, Science Writer, Los Angeles Times         

                                             Steven Woolf, Professor, Departments of Family Medicine, Epidemiology, and Community Health, Virginia Commonwealth University

                                             Vance Vanier, Chief Medical Officer, Navigenics

 

2:15 – 3:15 P.M.        Panel discussion

 

3:15 – 4:00 P.M.        Roundtable discussion

 

4:00 – 5:00 P.M.       Summary and wrap up discussion

 

Back to Meeting